Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Non Operating Income (2020 - 2024)

Historic Non Operating Income for CureVac (CVAC) over the last 5 years, with Q4 2024 value amounting to $5.6 million.

  • CureVac's Non Operating Income rose 24430.02% to $5.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $968796.3, marking a year-over-year increase of 11914.76%. This contributed to the annual value of $14.1 million for FY2024, which is 767.68% down from last year.
  • CureVac's Non Operating Income amounted to $5.6 million in Q4 2024, which was up 24430.02% from $1.6 million recorded in Q4 2023.
  • CureVac's 5-year Non Operating Income high stood at $5.6 million for Q4 2024, and its period low was -$12.8 million during Q4 2020.
  • Its 5-year average for Non Operating Income is -$1.7 million, with a median of $336128.1 in 2021.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 74212.99% in 2022, then soared by 24430.02% in 2024.
  • Over the past 5 years, CureVac's Non Operating Income (Quarter) stood at -$12.8 million in 2020, then surged by 108.97% to $1.1 million in 2021, then tumbled by 742.13% to -$7.3 million in 2022, then soared by 121.97% to $1.6 million in 2023, then surged by 244.3% to $5.6 million in 2024.
  • Its Non Operating Income was $5.6 million in Q4 2024, compared to $1.6 million in Q4 2023 and -$7.3 million in Q4 2022.